1 min read
Add as a preferred source on GoogleBoston Scientific Sets 2026 Earnings Outlook Below Consensus
Third-quarter revenue reached $5.14 billion, while non-GAAP earnings were 73 cents per share, 1 cent above estimates.
Boston Scientific set its 2026 adjusted earnings outlook at $3.16 to $3.18 a share, below the $3.23 consensus estimate, while reporting third-quarter revenue growth of 1.4%.
Revenue totaled $5.14 billion, $90 million above consensus. Non-GAAP earnings were 73 cents per share, beating estimates by 1 cent.
The company forecast reported sales growth of about 4.25% for 2026.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.